Edward W. Roberts
- Immunology top 0.2%
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 7
- Immune cells in cancer 7
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 4
- Peptidase Inhibition and Analysis 3
- Cancer Research top 1%
- Molecular Biology top 2%
- Biotechnology top 1%
-
- Advanced Materials Characterization Techniques 6
-
- Influenza Virus Research Studies 3
- Co-authors
- Matthew F. KrummelDouglas T. FearonMikhail BinnewiesLisa M. CoussensVincent ChanKelly KerstenDmitry I. GabrilovichWeiping Zou
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Edward W. Roberts
35 papers receiving 9.8k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Immunology 4.9k
- Oncology 5.9k
- Cancer Research 1.6k
- Molecular Biology 3.1k
- Biotechnology 353
Countries citing papers authored by Edward W. Roberts
This map shows the geographic impact of Edward W. Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward W. Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward W. Roberts more than expected).
Fields of papers citing papers by Edward W. Roberts
This network shows the impact of papers produced by Edward W. Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward W. Roberts. The network helps show where Edward W. Roberts may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edward W. Roberts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 27 | |
| 8 | 2023 | 14 | |
| 9 | 2022 | 17 | |
| 10 | 2020 | 160 | |
| 11 | Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunitybreakdown → | 2019 | 443 |
| 12 | Understanding the tumor immune microenvironment (TIME) for effective therapybreakdown → | 2018 | 3986 |
| 13 | 2016 | 270 | |
| 14 | 2016 | 317 | |
| 15 | Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanomabreakdown → | 2016 | 729 |
| 16 | 2014 | 98 | |
| 17 | Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–αbreakdown → | 2010 | 918 |
| 18 | 2009 | 36 | |
| 19 | Organic Extracellular Matrix Components at the Bone Cell/Substratum Interface | 1993 | 17 |
| 20 | Update: Fluidization for Tidal Channel Maintenance | 1987 | 1 |
About Edward W. Roberts
Edward W. Roberts is a scholar working on Immunology, Oncology and Modeling and Simulation, having authored 41 papers that have together received 10.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (7 papers), Immune cells in cancer (7 papers), Advanced Materials Characterization Techniques (6 papers), CAR-T cell therapy research (4 papers), Influenza Virus Research Studies (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Immunology (4.9k citations), Oncology (5.9k citations) and Cancer Research (1.6k citations). Edward W. Roberts has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Matthew F. Krummel, Douglas T. Fearon, Mikhail Binnewies, Lisa M. Coussens, Vincent Chan, Kelly Kersten, Dmitry I. Gabrilovich, Weiping Zou, Suzanne Ostrand‐Rosenberg and Catherine C. Hedrick. Their work appears in journals such as Surface Science, Nature Communications, Cancer Cell, Proceedings of the National Academy of Sciences and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.